EBITDA for Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's current EBITDA (TTM) is $16.78B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PFE
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$16.78B
YoY change
-16.7%
5Y CAGR
+2.8%
Peak year (2022)
$41.03B
Cumulative EBITDA
$509.46B
EBITDA history chart for Pfizer (PFE) from 1985 to 2025
EBITDA history table for Pfizer (PFE) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $15.10B | -16.7% | ||
| 2024 | $18.13B | +89.7% | ||
| 2023 | $9.56B | -76.7% | ||
| 2022 | $41.03B | +33.2% | ||
| 2021 | $30.79B | +133.8% | ||
| 2020 | $13.17B | -30.2% | ||
| 2019 | $18.85B | -3.7% | ||
| 2018 | $19.59B | -1.3% | ||
| 2017 | $19.84B | +29.8% | ||
| 2016 | $15.29B | -0.2% | ||
| 2015 | $15.32B | -19.9% | ||
| 2014 | $19.14B | -18.7% | ||
| 2013 | $23.54B | +15.3% | ||
| 2012 | $20.42B | -8.0% | ||
| 2011 | $22.19B | +13.4% | ||
| 2010 | $19.57B | +16.3% | ||
| 2009 | $16.82B | +9.9% | ||
| 2008 | $15.30B | +2.9% | ||
| 2007 | $14.88B | -20.9% | ||
| 2006 | $18.81B | +11.6% | ||
| 2005 | $16.85B | -13.4% | ||
| 2004 | $19.45B | +35.1% | ||
| 2003 | $14.39B | +8.5% | ||
| 2002 | $13.26B | +14.4% | ||
| 2001 | $11.59B | +21.5% | ||
| 2000 | $9.54B | +21.2% | ||
| 1999 | $7.87B | +28.0% | ||
| 1998 | $6.15B | +75.6% | ||
| 1997 | $3.50B | +12.9% | ||
| 1996 | $3.10B | +5.7% | ||
| 1995 | $2.93B | +29.6% | ||
| 1994 | $2.26B | +93.3% | ||
| 1993 | $1.17B | -31.4% | ||
| 1992 | $1.71B | +14.0% | ||
| 1991 | $1.50B | +17.1% | ||
| 1990 | $1.28B | +8.8% | ||
| 1989 | $1.18B | -2.6% | ||
| 1988 | $1.21B | +9.4% | ||
| 1987 | $1.10B | -0.4% | ||
| 1986 | $1.11B | +9.6% | ||
| 1985 | $1.01B | — |
EBITDA values are taken from Pfizer's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Pfizer (PFE) EBITDA is $15.10B – declined 16.7% year-over-year.
Through 2020–2025 (5 years), Pfizer EBITDA delivered a +2.8% annualised rate; with the latest reading among the more recent periods of the dataset.
Pfizer EBITDA peaked at $41.03B in 2022; the latest annual figure is $15.10B in 2025 (63.2% below peak).
2022 marks the peak EBITDA at $41.03B, with the historical low of $1.01B recorded in 1985.
Among 8 Healthcare peers, Pfizer (PFE) ranks 9th; the peer median for EBITDA is $24.21B.
Pfizer EBITDA by Year
Pfizer EBITDA 2025: $15.10B
Pfizer EBITDA in 2025 was $15.10B, declined 16.7% below 2024.
Pfizer EBITDA 2024: $18.13B
Pfizer EBITDA in 2024 was $18.13B, surged 89.7% from 2023.
Pfizer EBITDA 2023: $9.56B
Pfizer EBITDA in 2023 was $9.56B, plunged 76.7% below 2022.
Pfizer EBITDA 2022: $41.03B
Pfizer EBITDA in 2022 was $41.03B, surged 33.2% from 2021. This figure represents the highest annual value in the available history.
Pfizer EBITDA 2021: $30.79B
Pfizer EBITDA in 2021 was $30.79B.
See more financial history for Pfizer (PFE).
Sector peers — EBITDA
Companies in the same sector as Pfizer, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Pfizer's EBITDA?
- Latest reported EBITDA for Pfizer (PFE) is $16.78B (period ending December 31, 2025).
How has Pfizer EBITDA changed year-over-year?
- Pfizer (PFE) EBITDA changed -16.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Pfizer EBITDA?
- Pfizer (PFE) EBITDA compound annual growth rate is +2.8% over the most recent 5 years available.
When did Pfizer EBITDA hit its highest annual value?
- Pfizer EBITDA reached its highest annual value of $41.03B in 2022.
What was Pfizer EBITDA in 2024?
- Pfizer (PFE) EBITDA in 2024 was $18.13B.
What was Pfizer EBITDA in 2025?
- Pfizer (PFE) EBITDA in 2025 was $15.10B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PFE Overview
Company profile, financial tools, and key metrics
PFE Revenue Counter
Earns $1,984 every second. See per minute, hour, and day.
PFE Earnings Counter
Earns $246.39 per second net profit. See per minute, hour, and day.
PFE Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
PFE What If Invested
What if you had invested $1,000? See historical returns from any date.
PFE How It Makes Money
Discover visual breakdown of $62.58B in revenue — where it comes from and where it goes.
PFE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PFE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PFE Daily Price Character
Steady · 46.3% historical win rate (green days). Streaks & record days.
PFE Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
PFE Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
PFE Dividend Profile
Yield: 6.55%. Safety: 3/8. See full history.
PFE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
PFE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.